Michelle Hylan is a seasoned professional in the clinical research and operations sector, currently serving as the Founder and CEO of Innov8tive Research Consulting since May 2014. In addition to this role, Michelle Hylan holds the position of Head of Clinical Operations at Myrtelle and serves as Chief Operating Officer at Telocyte, both starting in July 2024 and November 2022, respectively. Michelle Hylan has contributed as a Clinical Consultant at Rhythm Pharmaceuticals Inc., Regenacy Pharmaceuticals LLC, HemoShear Therapeutics, and Allena Pharmaceuticals, with tenure extending from June 2014 to December 2025. Prior experience includes serving as Principal Consultant at Halloran Consulting Group, as well as consulting roles at Novartis Vaccines and Diagnostics. Educational credentials include studies at Connecticut College and Wellesley College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices